Timothy Stenzel has been spending his time helping lead development of new companion diagnostics and next-generation sequencing panels. Now he will be the point person for regulating these products in the US.
Stenzel, who since 2014 has served as chief operating officer of Invivoscribe Technologies Inc., a molecular diagnostics company and laboratory, joined FDA late last month to head up its...